Andy Cross

How do you think about trying to determine those AI contenders from the AI pretenders when you're looking at it as an analyst and as an investor in companies you might be studying and thinking about investing in?

Yeah, and having founders like Toby who own meaningful stakes and are all in like that and very vocal about it is a good indication of that exactly, Tom.

Yeah, a lot of sweat equity, real equity and sweat equity into those kinds of decisions.

You remain cautious and moderate with your investing stance, but the AI powered indicator that you use in hidden gems actually turned more positive about the markets.

Why and has it impacted your thinking?

Maybe define what that tool is and how it's impacted your thinking.

It's hard to believe that AI could be more dramatic with the markets than those Internet years were that you spoke about.

You know, as you mentioned, the Nasdaq had fallen about 75 percent back then.

The business world seemed to basically collapse.

So do you think that could really happen with AI or could it be even more dramatic than the Internet?

Tom, let's wrap up here and look at the next, say, five years, because we're long-term investors and we always focus on the next five years and beyond.

How about one cautious, one moderate, and one aggressive stock looking out?

Ah, blast from the past there.

Awesome.

So not just three, but six.

Thanks for bringing two for each category, Tom.

Oh, gosh.

One, the moderate one, moderate to growth one is MedPace, M-E-D-P, which is a contract research organization tied very heavily to biotech funding, which is starting to pick up.

And so I think this year we'll see a little bit more pickup of that, especially if interest rates start to moderate, we'll see more pickup.

And they just have a great leadership position.